0001193125-23-009443.txt : 20230117 0001193125-23-009443.hdr.sgml : 20230117 20230117162303 ACCESSION NUMBER: 0001193125-23-009443 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230117 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORE LABORATORIES N V CENTRAL INDEX KEY: 0001000229 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14273 FILM NUMBER: 23531812 BUSINESS ADDRESS: STREET 1: VAN HEUVEN GOEDHARTLAAN 7 B CITY: 1181 LE AMSTELVEEN STATE: P7 ZIP: 1181 LE BUSINESS PHONE: 3124203191 MAIL ADDRESS: STREET 1: 6316 WINDFERN CITY: HOUSTON STATE: TX ZIP: 77040 8-K 1 d431525d8k.htm 8-K 8-K
CORE LABORATORIES N V 00-0000000 false 0001000229 0001000229 2023-01-17 2023-01-17

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 17, 2023

 

 

CORE LABORATORIES N.V.

(Exact name of registrant as specified in its charter)

 

 

 

The Netherlands   001-14273   Not Applicable
(State or Other Jurisdiction
of Incorporation)		   (Commission
File Number)		   (I.R.S. Employer
Identification No.)

 

Van Heuven Goedhartlaan 7B

1181 LE Amstelveen

The Netherlands

   Not Applicable
(Address of Principal Executive Office)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (31-20) 420-3191

Not Applicable

(Former Name or Former Address, If Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☒

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock (Par Value EUR 0.02)   CLB   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

ITEM 8.01

Other Events.

On January 17, 2023, Core Laboratories N.V. (“Core Lab” or the “Company”) issued a news release announcing its intention to reorganize the Company’s corporate structure, which will include redomestication (the “Redomestication”) of the parent company from the Netherlands to the United States as Core Laboratories, Inc., a Delaware corporation (“Core Lab Delaware”). Following shareholder approval, the Redomestication will be completed through a series of steps, as follows: (i) Core Laboratories N.V. will merge with and into Core Laboratories Luxembourg S.A., with Core Laboratories Luxembourg S.A. surviving, and (ii) as soon as practicable thereafter, Core Laboratories Luxembourg S.A. will migrate out of Luxembourg and redomesticate into the State of Delaware, as Core Lab Delaware, which will become Core Lab’s ultimate parent company. A copy of the news release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

In connection with the Redomestication, on January 17, 2023, Core Laboratories Luxembourg S.A., which is currently a wholly-owned subsidiary of Core Lab and will be a predecessor of Core Lab Delaware following the completion of the Redomestication, filed a Registration Statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus of Core Lab Delaware and preliminary proxy statement of the Company (the “Proxy Statement/Prospectus”), with the Securities and Exchange Commission (the “SEC”). The information in the Registration Statement, including the information in the Proxy Statement/Prospectus, is subject to completion and amendment.

Important Information for Investors and Securityholders

This communication is not intended to and does not constitute an offer to sell, buy or exchange or the solicitation of an offer to sell, buy or exchange any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, purchase, or exchange of securities or solicitation of any vote or approval in any jurisdiction in contravention of applicable law. In connection with the proposed corporate reorganization that includes, among other things, the Redomestication, Core Laboratories Luxembourg S.A., a predecessor to Core Lab Delaware, has filed a registration statement on Form S-4, which includes Core Lab Delaware’s prospectus as well as the Company’s proxy statement (the “Proxy Statement/Prospectus”), with the U.S. Securities and Exchange Commission (the “SEC”). The Company plans to mail the definitive Proxy Statement/Prospectus to its shareholders in connection with the proposed corporate reorganization. INVESTORS AND SECURITYHOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, CORE LAB DELAWARE, THE CORPORATE REORGANIZATION AND RELATED MATTERS. Investors and securityholders will be able to obtain free copies of the definitive Proxy Statement/Prospectus (when available) and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov. In addition, investors and securityholders will be able to obtain free copies of the documents filed with the SEC on the Company website at www.corelab.com or by contacting the Company’s Corporate Secretary.

Participants in the Solicitation

The Company and certain of its directors, executive officers and employees may be considered participants in the solicitation of proxies in connection with the proposed corporate reorganization. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the securityholders of the Company in connection with the corporate reorganization, including a description of their respective direct or indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus described above when it is filed with the SEC. Additional information regarding the Company’s directors and executive officers is also included in the Company’s 2022 Proxy Statement, which was filed with the SEC on March 22, 2022. This document is available free of charge as described above.

Forward-Looking Statements

This communication, as well as other statements we make, includes forward-looking statements made in reliance upon the safe harbor provisions of Federal securities law, including statements regarding: completion of the corporate reorganization that includes, among other things, the establishment of a new company domiciled in the U.S. and the timing and benefits thereof; the future revenue, profitability, business strategies and developments of the Company.

 

1

These forward-looking statements are subject to various important cautionary factors, including: the ability to receive, in a timely manner and on satisfactory terms, required securityholder, stock exchange and court approvals; ability to achieve anticipated benefits of the corporate reorganization; publicity resulting from the reorganization and impacts to the company’s business and share price; risks and uncertainties related to the oil and natural gas industry; business and general economic conditions, including inflationary pressures, international markets, international political climates, including the Russia-Ukraine geopolitical conflict, public health crises, such as the COVID-19 pandemic; and any related actions taken by businesses and governments, and other factors as more fully described in the Company’s most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company’s actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company’s performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company’s future performance.

The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this communication, except as required by law.

 

Item 9.01

Financial Statements and Exhibits.

 

  (d)

Exhibits.

 

Exhibit
No.		   

Description

Exhibit 99.1    News Release dated January 17, 2023.
Exhibit 104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Core Laboratories N.V.
Dated: January 17, 2023
    By:  

/s/ Christopher S. Hill

            Christopher S. Hill
            Chief Financial Officer

 

3

 EX-99.1 2 d431525dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO                 

FOR IMMEDIATE RELEASE

CORE LAB ANNOUNCES PROPOSED REDOMESTICATION TO THE UNITED STATES

AMSTERDAM (17 January 2023)—Core Laboratories N.V. (NYSE: “CLB US”) (“Core”, “Core Lab”, or the “Company”) announces the Company’s Board of Directors has approved a plan to reorganize the Company’s corporate structure, which will include redomestication of the parent company from the Netherlands to the United States (the “Redomestication”). The Company and its Board believes that the Redomestication will enhance shareholder value over the long-term through simplifying the corporate structure, improving operational efficiencies and reducing administrative costs. The Redomestication will, if completed, change the Company’s jurisdiction of organization from the Netherlands to the State of Delaware.

Following shareholder approval, the Redomestication will be completed through a series of steps, as follows: (i) Core Laboratories N.V. will merge with and into Core Laboratories Luxembourg S.A., with Core Laboratories Luxembourg S.A. surviving, and (ii) as soon as practicable thereafter, Core Laboratories Luxembourg S.A. will migrate out of Luxembourg and redomesticate into the State of Delaware, as Core Laboratories Inc. (“Core Lab Delaware”), which will become Core’s ultimate parent company. Upon completion of the transaction, Core Laboratories N.V. shareholders will hold one share of Common Stock of Core Lab Delaware for each Common Share of Core Laboratories N.V. owned immediately prior to the Redomestication. Core Lab N.V. Common Shares will continue to trade on the New York Stock Exchange (“NYSE”) up to and including the effective date of the Redomestication. Following the effective date of the Redomestication, shares of Common Stock of Core Lab Delaware will be listed on the NYSE under the ticker symbol “CLB”. The Company’s shares will continue to trade uninterrupted during and upon completion of the Redomestication.

Benefits from the Redomestication will include: (i) a reduced corporate footprint and a reduction in regulatory requirements associated with audited financial statements, financial reporting, and compliance with other statutory regulations, (ii) improved efficiencies and opportunities in the Company’s corporate treasury, cash management, risk management and tax functions, and (iii) a simplified and more efficient tax structure.

The Redomestication requires a shareholder vote for approval, which will be conducted through an extraordinary general meeting of Core Lab shareholders, which is anticipated to occur early in the second quarter of 2023. Further details are provided in the Company’s preliminary proxy statement/prospectus, filed with the U.S. Securities and Exchange Commission (“SEC”) on 17 January 2023.

Important Information for Shareholders

This communication is not intended to and does not constitute an offer to sell, buy or exchange or the solicitation of an offer to sell, buy or exchange any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, purchase, or exchange of securities or solicitation of any vote or approval in any jurisdiction in contravention of applicable law. In connection with the proposed corporate reorganization that includes, among other things, the Redomestication, Core Laboratories Luxembourg S.A., a predecessor to Core Lab Delaware, has filed a registration statement on Form S-4, which includes Core Lab Delaware’s prospectus as well as the Company’s proxy statement (the “Proxy Statement/Prospectus”), with the SEC. The Company plans to mail the definitive Proxy Statement/Prospectus to its shareholders in connection with the proposed corporate reorganization. INVESTORS AND SECURITYHOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, CORE LAB DELAWARE, THE CORPORATE REORGANIZATION AND RELATED MATTERS.    Investors and securityholders will be able to obtain free copies of the definitive Proxy Statement/Prospectus (when available) and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov. In addition, investors and securityholders will be able to obtain free copies of the documents filed with the SEC on the Company website at www.corelab.com or by contacting the Company’s Corporate Secretary.

Participants in the Solicitation

The Company and certain of its directors, executive officers and employees may be considered participants in the solicitation of proxies in connection with the proposed corporate reorganization. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the securityholders of the Company in connection with the corporate reorganization, including a description of their respective direct or indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus described above when it is filed with the SEC. Additional information regarding the Company’s directors and executive officers is also included in the Company’s 2022 Proxy Statement, which was filed with the SEC on March 22, 2022. This document is available free of charge as described above.

About Core Lab

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world.

Visit the Company’s website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

Forward-Looking Statements

This release, as well as other statements we make, includes forward-looking statements made in reliance upon the safe harbor provisions of Federal securities law, including statements regarding: completion of the corporate reorganization that includes, among other things, the establishment of a new company domiciled in the U.S. and the timing and benefits thereof; the future revenue, profitability, business strategies and developments of the Company. These forward-looking statements are subject to various important cautionary factors, including: the ability to receive, in a timely manner and on satisfactory terms, required securityholder, stock exchange and court approvals; ability to achieve anticipated benefits of the corporate reorganization; publicity resulting from the reorganization and impacts to the company’s business and share price; risks and uncertainties related to the oil and natural gas industry; business and general economic conditions, including inflationary pressures, international markets, international political climates, including the Russia-Ukraine geopolitical conflict, public health crises, such as the COVID-19 pandemic; and any related actions taken by businesses and governments, and other factors as more fully described in the Company’s most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company’s actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company’s performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company’s future performance.

The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

For more information, contact:

Gwen Gresham—SVP Corporate Development and Investor Relations, +1 713 328 6210

EX-101.SCH 3 clb-20230117.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 clb-20230117_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country Country Region Country Region City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key EX-101.PRE 5 clb-20230117_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g431525g0117072025067.jpg GRAPHIC begin 644 g431525g0117072025067.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Jan. 17, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jan. 17, 2023
Entity Registrant Name CORE LABORATORIES N V
Entity Incorporation, State or Country Code P7
Entity File Number 001-14273
Entity Tax Identification Number 00-0000000
Entity Address, Address Line One Van Heuven Goedhartlaan 7B
Entity Address, Postal Zip Code 1181 LE
Entity Address, City or Town Amstelveen
Entity Address, Country NL
Country Region 31
City Area Code 20
Local Phone Number 420-3191
Written Communications true
Soliciting Material true
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock (Par Value EUR 0.02)
Trading Symbol CLB
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001000229
XML 8 d431525d8k_htm.xml IDEA: XBRL DOCUMENT 0001000229 2023-01-17 2023-01-17 CORE LABORATORIES N V 00-0000000 false 0001000229 8-K 2023-01-17 P7 001-14273 Van Heuven Goedhartlaan 7B 1181 LE Amstelveen NL 31 20 420-3191 true true false false Common Stock (Par Value EUR 0.02) CLB NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - d431525d8k.htm 7 d431525d8k.htm clb-20230117.xsd clb-20230117_lab.xml clb-20230117_pre.xml d431525dex991.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d431525d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "d431525d8k.htm" ] }, "labelLink": { "local": [ "clb-20230117_lab.xml" ] }, "presentationLink": { "local": [ "clb-20230117_pre.xml" ] }, "schema": { "local": [ "clb-20230117.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "clb", "nsuri": "http://corelab.com/20230117", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d431525d8k.htm", "contextRef": "duration_2023-01-17_to_2023-01-17", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d431525d8k.htm", "contextRef": "duration_2023-01-17_to_2023-01-17", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://corelab.com//20230117/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001193125-23-009443-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-009443-xbrl.zip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end